Health & Environmental Research Online (HERO)


Print Feedback Export to File
6329579 
Journal Article 
Enhancement of the intestinal absorption of peptides and nonpeptides 
Aungst, BJ; Saitoh, H; Burcham, DL; Huang, SM; Mousa, SA; Hussain, MA 
1996 
Yes 
Journal of Controlled Release
ISSN: 0168-3659
EISSN: 1873-4995 
ELSEVIER SCIENCE BV 
AMSTERDAM 
41 
1-2 
19-31 
WOS:A1996VB46400003 
It is not uncommon for peptides and structurally-similar non-peptides to have poor intestinal permeability and low oral bioavailability. One possible way to solve a permeability problem is to formulate the compound with membrane permeation-enhancing excipients. Important criteria for success of this approach are: (1) achieving reproducible intestinal permeation, (2) doing so without causing toxicity, and (3) understanding the mechanisms of permeation enhancement. Some effective and potentially safe permeation enhancers are fatty acids, glycerides, surfactants, acyl carnitines, and bile salts. The literature on permeation enhancement with these agents is briefly reviewed. We evaluated permeation enhancement approaches to increase the oral bioavailability of a non-metabolized, cyclic peptide fibrinogen antagonist, DMP 728. Sodium caprate (15 mM) increased the in vitro intestinal permeation rate 3-fold. Oral absorption in dogs was also increased approximately 3-fold using a formulation containing 150 mg sodium caprate. Inter-animal variability in absorption was considerable, though. A diacidic, non-peptide angiotensin II antagonist, DuP 532, presented another case of a poorly membrane permeable lead compound. Sodium caprate did not affect DuP 532 oral bioavailability in rats. However, oral bioavailability of DuP 532 in rats and dogs was increased approximately 3-fold using glyceride vehicles. These excipients have the advantage of already being used in marketed products. As with DMP 728, there was substantial inter-animal variability of DuP 532 oral bioavailability, and optimization of the formulation would be required to improve reproducibility. These examples demonstrate the possibilities of significantly improving oral bioavailability of poorly permeable drugs using seemingly acceptable excipients. 
oral absorption; intestinal permeation; enhancement; bioavailability 
5th International Symposium on Delivery and Targeting of Peptides, Proteins and Genes 
LEIDEN, NETHERLANDS